Case Study: AstraZeneca achieves faster Windows updates and more efficient testing with Microsoft Corporation

AstraZeneca streamlines testing and speeds updates with Windows as a service

AstraZeneca, one of the world’s largest biopharmaceutical companies, manages more than 70,000 Windows devices and was challenged by the heavy effort required to test, validate, and deploy major Windows upgrades. With Microsoft Corporation’s Windows 10 and Windows as a service approach, the company needed a way to make updates smaller, faster, and less disruptive for users and IT teams.

Microsoft Corporation implemented Windows 10 servicing tools including Configuration Manager, Windows Analytics, Microsoft 365, and the Windows Insider Program to improve testing, remediation, and deployment. AstraZeneca now uses semiannual feature updates and monthly cumulative updates with deferral policies, which has made testing more efficient and accelerated rollouts; users also get new features sooner, improving productivity and reducing update overhead.

AstraZeneca

Andy Thorp

Platform Architect